Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationBlood DonorsMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsTransplantation ConditioningHematopoietic Stem CellsBlood BanksGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell MobilizationAntigens, CD34Tissue DonorsBone Marrow TransplantationGraft SurvivalMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyTreatment OutcomeTransplantation ChimeraCell DifferentiationBusulfanMyeloablative AgonistsMultiple MyelomaCyclophosphamideBlood Component RemovalRecurrenceHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsRemission InductionMice, SCIDLiver TransplantationHistocompatibilityWhole-Body IrradiationCells, CulturedRetrospective StudiesImmunosuppressive AgentsLeukemiaLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingVidarabineMesenchymal Stem Cell TransplantationDisease-Free SurvivalGraft vs Leukemia EffectInfectionHematopoiesisEtoposideTime FactorsSurvival RateThiotepaKidney TransplantationSurvival AnalysisTransplantation, IsogeneicSalvage TherapyCell TransplantationHematologic DiseasesLeukemia, Myeloid, AcuteEmbryonic Stem CellsPOEMS SyndromeAmyloidosisBlood CellsSpinal CordHodgkin DiseaseHLA AntigensMyelodysplastic SyndromesAdult Stem CellsCytomegalovirus InfectionsDonor SelectionCytarabineFollow-Up StudiesAnemia, AplasticVincristineLiving DonorsMice, Inbred NODLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFatal OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaCarmustineLymphomaTransplantation ImmunologyLymphocyte DepletionPlatelet Count